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Lab automation: the dramatic impact of drug
discovery
Los Angeles, CA, 9 September 1999Ð Strategic Directions
International ispleased to announce the publication of its
latest Market Analyses and Perspectives (MAP) research
report entitled Lab Automation: The Dramatic Impact of
Drug Discovery. This report provides a detailed picture
of the current market for various laboratory automation
techniques and includes an in-depth forecast till 2003.
Laboratory automation products discussed in this report
include microplate readers, microplate auxiliary equip-
ment, diluters/dispensers, XYZ workstations, organic
synthesizers, automated solid phase extraction appara-
tuses, robotic stackers/arms, integrated robotic platforms,
and software.
Liquid handlers, the largest segment of the laboratory
automation products included in this report, generated
worldwide revenues of $465 million in 1998. Annual
growth for this most important segment is forecasted at
¹15% per year for the next 5 years, contributing to a
total lab automation market of ¹$2.1 billion by 2003.
Driven by the pharmaceutical and biotechnology indus-
tries’ focus on high-throughput screening and combina-
torial chemistry methods, demand for liquid handlers has
experienced renewed growth in recent years.
Although liquid handlers currently account for the
largest segment of the lab automation market, the fastest
growth is expected to come from software. Speci® cally,
cheminformatics software and integrated automation
software are anticipated to grow at over 20% per year
for the next 5 years.
Owing to bene® ts such as higher throughput, fewer
error-prone tasks, and more reproducible results, many
industries ® nd laboratory automation an attractive
investment. Accordingly, this renewed interest in lab
automation has put it on a new growth curve. The
pharmaceutical industry will continue to be the largest
and fastest growing sector with demand expected to
exceed $700 million by 2003.
This report assesses the lab automation market by major
product types including: microplate readers and auxili-
ary equipment, diluters/dispensers, XYZ workstations,
organic synthesizers, automated solid-phase extraction
apparatus, robotic stackers/arms, integrated robotic plat-
forms, and software. Secondary screening instruments,
e.g. high-performance liquid chromatography (HPLC),
mass spectrometry (MS) and nuclear magnetic resonance
spectroscopy (NMR) are also discussed and quanti® ed in
relation to their role in drug discovery applications.
Additionally, the market is segmented by geographic
region and industry. Included in the report are company
pro® les, competitive analyses and market shares, as well
as end-user opinions. This 229 page report, containing
121 tables and 134 ® gures, provides a complete analysis
of the market at the price of $3895.
For more information please contact Strategic Directions Inter-
national, 6242 Westchester Parkway, Suite 100, Los Angeles, CA
90045, USA. Tel: + 1 (310) 641-4982; Fax: + 1 ( 310) 641-
8851; e-mail: sdi@strategic-directions.com or Biote Postale 7,
78131 Les Mureaux Cedex, France. Tel: + 33 ( 1) 30 99 62 50;
Fax: + 33 (1) 34 74 81 62; e-mail: sdi_europe@compuserve.
com
Strategic Directions International, based in Los Angeles,
CA, is the leading international consulting company in
the specialized ® eld of analytical instrumentation. Our
dedication to the ® eld allows us to o￿ er our clients a high
level of detail and insight that comes from constantly
monitoring the developments in the industry. News
releases and other information about SDi are available
at www.strategic-directions.com
HP Launches the ￿ rst product based on ‘lab-on-a-
chip’ technology
Geneva, Switzerland, 24 September 1999Ð Hewlett-Packard
Europe today introduced the HP2100 bioanalyser for the
integrated analysis of nucleic acids. This is the ® rst
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123commercially available product utilizing lab-on-a-chip
technology.
Based on Caliper Technologies’ LabChip
TM technology,
the system marks a major step toward the development of
a completely automated microscale laboratory. In this
`lab-on-the-chip’, all sample preparation, ¯ uid handling
and biochemical analysis steps will be carried out within
the con® nes of a microchip. The chips comprise micro-
channels that create interconnected networks of ¯ uid
reservoirs and pathways.
Used together with various LabChip kits, the HP 2100
bioanalyser improves the quality of nucleic acid analysis
by integrating sample handling, separation, detection
and digital data processing within a single, compact
system architecture. The system is designed for use by
molecular biologists and biochemists working with poly-
merase chain reaction (PCR) products, restriction en-
zyme digests or ribonucleic acid (RNA) preparations.
Implications for life-science research
Researchers in the areas of disease and drug discovery
still experience manual processing bottlenecks during the
analysis of nucleic acids. LabChip technology o￿ ers
many bene® ts over the existing manual gel electrophor-
esis products.
. Improved accuracy. The integrated, miniaturized chip
design drastically cuts system retention and material
transfer losses, improving accuracy and reducing
sample consumption.
. Rapid analysis. Miniaturized ¯ uid pathways
dramatically shorten run times. Each nucleic acid
sample is analysed in 90s.
. Enhanced reproducibility. State-of-the-art fabrication
processes yield chips that perform more repro-duc-
ibly than conventional gel products. Automated
¯ uid handling, using standardized experimental
protocols, further enhances performance.
Initial applications
The HP 2100 bioanalyser is o￿ ered with three intro-
ductory assays. Each assay is packaged as a complete,
ready-to-use kit.
. DNA 7500 LabChip kit for accurate sizing and
quantitation of DNA fragments ranging in size
from 100 to 7500bp.
. DNA 12000 LabChip kit for accurate sizing of DNA
fragments from 100 to 12000bp.
. RNA 6000 LabChip kit for the analysis and quan-
titation of total RNA and mRNA samples.
Pricing and availability
The HP 2100 bioanalyser is initially available in
Germany, Switzerland and the USA. It can be ordered
directly through HP chemical analysis products sales
o￿ ces in each of these countries. The price of the
complete system is approximately Euro 20000 and
delivery is estimated at 6 weeks from receipt of order.
The system is expected to be available in additional
European countries and Japan by the end of 2000.
About HP’s Chemical Analysis Group
HP’s Chemical Analysis Group, with headquarters in
Palo Alto, CA, USA, is a leading provider of chemical
analysis measurement and information solutions, services
and support, columns and supplies to scienti® c labora-
tories in industry, government and academia. The group
has 3789 employees worldwide and had revenues of $946
million in its 1998 ® scal year.
Information about LabChip products, can be found on
the World Wide Web at http://www.hp.com/go/labona-
chip
About HP
Hewlett-Packard CompanyÐ a leading global provider
of computing and imaging solutions and services for
business and homeÐ is focused on capitalising on the
opportunities of the Internet and the proliferation of
electronic services.
HP plans to launch Agilent Technologies as an indepen-
dent company by mid-calendar year 2000. Agilent con-
sists of HP’s test and measurement, semiconductor
products, chemical analysis and healthcare solutions
businesses, and has leading positions in multiple market
segments.
HP has 123500 employees worldwide and had a total
revenue of $47.1 billion in its 1998 ® scal year. Informa-
tion about HP, its products and the company’sYear 2000
program can be found on the World Wide Web at http://
www.hp.com
LabChip
TM and the LabChip logo are USA trademarks
of Caliper Technologies Corporation.
Hewlett-Packard Company has introduced the HP 2100
bioanalyser for the integrated analysis of nucleic acids.
This is the ® rst commercially available product utilizing
lab-on-a-chip technology.
Please send reader enquiries to: Hewlett-Packard Europe, PO
Box 165, Godalming, Surrey GU7 1WD,UK
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